Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Convertible Debt (2016 - 2017)

Historic Convertible Debt for Lexaria Bioscience (LEXX) over the last 5 years, with Q2 2017 value amounting to $45000.0.

  • Lexaria Bioscience's Convertible Debt changed 0.0% to $45000.0 in Q2 2017 from the same period last year, while for May 2017 it was $45000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $45000.0 for FY2016, which is N/A changed from last year.
  • According to the latest figures from Q2 2017, Lexaria Bioscience's Convertible Debt is $45000.0, which was down 0.0% from $45000.0 recorded in Q1 2017.
  • In the past 5 years, Lexaria Bioscience's Convertible Debt ranged from a high of $45000.0 in Q2 2016 and a low of $45000.0 during Q2 2016